A detailed history of Bayforest Capital LTD transactions in Mckesson Corp stock. As of the latest transaction made, Bayforest Capital LTD holds 321 shares of MCK stock, worth $270,310. This represents 0.12% of its overall portfolio holdings.

Number of Shares
321
Previous 1,110 71.08%
Holding current value
$270,310
Previous $813 Million 69.51%
% of portfolio
0.12%
Previous 0.36%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

SELL
$659.01 - $772.54 $519,958 - $609,534
-789 Reduced 71.08%
321 $248 Million
Q2 2025

Jul 28, 2025

BUY
$652.83 - $732.78 $724,641 - $813,385
1,110 New
1,110 $813 Million
Q4 2024

Feb 14, 2025

BUY
$482.27 - $628.5 $221,844 - $289,110
460 New
460 $262 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $121B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Bayforest Capital LTD Portfolio

Follow Bayforest Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayforest Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bayforest Capital LTD with notifications on news.